| Literature DB >> 32673249 |
Tânia Salgado1, Jorge Tavares1, Tiago Oliveira1.
Abstract
BACKGROUND: Mobile health (mHealth) has potential to play a significant role in realizing a reversal of the current paradigm in health care toward a more patient-centric and more collaborative system to improve the outcomes obtained along with the quality and sustainability of health care systems.Entities:
Keywords: UTAUT2; digital health; health management; mHealth; patient empowerment
Mesh:
Year: 2020 PMID: 32673249 PMCID: PMC7380904 DOI: 10.2196/17588
Source DB: PubMed Journal: JMIR Mhealth Uhealth ISSN: 2291-5222 Impact factor: 4.773
Electronic health (eHealth) adoption models.
| Theory | Dependent variable | Findings | Reference |
| TAMa, HBMb and TPBc | Health consumers’ behavior intention of using HITd | -PTe, PUf, and PEOUg significantly affected health consumers’ attitude and behavior intention. | [ |
| TAM and TPB | Internet use for health purposes | - Positive influence of perceived health risk and health consciousness on health-related internet use | [ |
| TAM2, Dual-factor model, HBM | Patient’s acceptance of smartphone health technology for chronic disease management | - PU of the app was positively influenced by the perceived health threat, relationship with doctor, and PEOU, but negatively affected by resistance to change | [ |
| UTAUT2h | EHRi portals | - Understanding of the adoption of EHR portals is improved through the use of consumer adoption-specific constructs | [ |
| Uses and gratification theory | eHealth usage by sociodemographic factors | - Female gender is a consistent predictor of eHealth usage | [ |
| TAM, UTAUT2 | Consumer acceptance of wearable self-tracking devices | - Positive influence of trust, perceived esthetics, personal innovativeness, perceived support of health, perceived support of fitness, and perceived support of well-being on consumer acceptance of wearables | [ |
| DMISSMj | Evaluation of trust, security beliefs, and privacy of HIT as determinants of health care outcomes | - Increased privacy concerns reduce the frequency of patient access to health records use, positive attitudes toward HIT, and perceptions of patient care quality | [ |
| Personal empowerment | Internet use behavior as a source of information | - Health information seeking is analyzed under three perspectives: professional logic, consumer logic, and community logic | [ |
| DITk | Factors impacting patient acceptance and use of consumer eHealth innovations | Health care providers need to consider and address patient characteristics, their social system, and preferences on communication channels, as well as the attributes of the innovation to guarantee its success. | [ |
aTAM: technology acceptance model.
bHBM: health belief model.
cTPB: theory of planned behavior.
dHIT: health information technology.
ePT: perceived threat.
fPU: perceived usefulness.
gPEOU: perceived ease of use.
hUTAUT2: extended unified theory of acceptance and usage of technology.
iEHR: electronic health record.
jDMISSM: DeLone and McLean information systems success model.
kDIT: diffusion of innovation theory.
Figure 1Research model. Original relationships from unified theory of acceptance and usage of technology (UTAUT2) are in black; new relationships from the extended model are in grey.
Sample characteristics.
| Characteristic | Total (N=322) | Chronic conditions group (n=124) | Healthy group (n=198) | ||||
| Age (years), mean (SD) | 40.03 (13.70) | 47.66 (14.30) | 35.26 (10.89) | ||||
|
|
|
|
| ||||
|
| Male | 93 (28.9) | 34 (27.4) | 59 (29.8) | |||
|
| Female | 229 (71.1) | 90 (72.6) | 139 (70.2) | |||
|
|
|
|
| ||||
|
| Middle school or lower | 11 (3.4) | 8 (6.5) | 3 (1.5) | |||
|
| High school | 61 (18.9) | 37 (29.8) | 24 (12.1) | |||
|
| Bachelor or postgraduate | 163 (50.6) | 54 (43.6) | 109 (55.1) | |||
|
| Master | 72 (22.4) | 17 (13.7) | 55 (27.8) | |||
|
| Doctorate | 15 (4.7) | 8 (6.5) | 7 (3.5) | |||
Total sample loadings and crossloadings.
| Constructs | PEa | EEb | SIc | HTd | FCe | HMf | PVg | PEMh | PEM-PLi | PEM-CLj | PEM-CCLk | BIl | BIRm | CAn | CRo | AVEp | ||||||||||||||||||||
|
| .90 | 0.94 | 0.84 | |||||||||||||||||||||||||||||||||
|
| PE1 |
| 0.37 | 0.44 | 0.52 | 0.31 | 0.40 | 0.23 | 0.52 | 0.51 | 0.50 | 0.40 | 0.56 | 0.55 |
|
|
| |||||||||||||||||||
|
| PE2 |
| 0.51 | 0.39 | 0.54 | 0.47 | 0.49 | 0.39 | 0.54 | 0.55 | 0.52 | 0.39 | 0.61 | 0.58 |
|
|
| |||||||||||||||||||
|
| PE3 |
| 0.48 | 0.38 | 0.52 | 0.41 | 0.42 | 0.37 | 0.55 | 0.59 | 0.52 | 0.39 | 0.63 | 0.59 |
|
|
| |||||||||||||||||||
| .93 | 0.95 | 0.82 | ||||||||||||||||||||||||||||||||||
|
| EE1 | 0.43 |
| 0.12 | 0.37 | 0.62 | 0.41 | 0.37 | 0.31 | 0.32 | 0.32 | 0.21 | 0.32 | 0.30 |
|
|
| |||||||||||||||||||
|
| EE2 | 0.51 |
| 0.27 | 0.50 | 0.66 | 0.51 | 0.43 | 0.39 | 0.39 | 0.37 | 0.30 | 0.42 | 0.38 |
|
|
| |||||||||||||||||||
|
| EE3 | 0.41 |
| 0.22 | 0.42 | 0.61 | 0.48 | 0.45 | 0.39 | 0.39 | 0.34 | 0.32 | 0.34 | 0.35 |
|
|
| |||||||||||||||||||
|
| EE4 | 0.44 |
| 0.13 | 0.41 | 0.64 | 0.43 | 0.41 | 0.34 | 0.36 | 0.33 | 0.24 | 0.38 | 0.30 |
|
|
| |||||||||||||||||||
|
| .97 | 0.98 | 0.94 | |||||||||||||||||||||||||||||||||
|
| SI1 | 0.43 | 0.21 |
| 0.58 | 0.29 | 0.40 | 0.27 | 0.55 | 0.52 | 0.47 | 0.48 | 0.47 | 0.48 |
|
|
| |||||||||||||||||||
|
| SI2 | 0.43 | 0.18 |
| 0.59 | 0.26 | 0.44 | 0.28 | 0.54 | 0.54 | 0.44 | 0.48 | 0.51 | 0.52 |
|
|
| |||||||||||||||||||
|
| SI3 | 0.40 | 0.21 |
| 0.59 | 0.28 | 0.43 | 0.31 | 0.55 | 0.56 | 0.45 | 0.47 | 0.51 | 0.52 |
|
|
| |||||||||||||||||||
|
| .87 | 0.91 | 0.73 | |||||||||||||||||||||||||||||||||
|
| HT1 | 0.52 | 0.46 | 0.53 |
| 0.45 | 0.59 | 0.41 | 0.53 | 0.54 | 0.46 | 0.43 | 0.64 | 0.56 |
|
|
| |||||||||||||||||||
|
| HT2 | 0.31 | 0.21 | 0.49 |
| 0.23 | 0.51 | 0.28 | 0.47 | 0.42 | 0.40 | 0.45 | 0.44 | 0.42 |
|
|
| |||||||||||||||||||
|
| HT3 | 0.61 | 0.39 | 0.55 |
| 0.40 | 0.57 | 0.44 | 0.62 | 0.64 | 0.53 | 0.49 | 0.71 | 0.68 |
|
|
| |||||||||||||||||||
|
| HT4 | 0.50 | 0.51 | 0.51 |
| 0.51 | 0.60 | 0.45 | 0.57 | 0.58 | 0.50 | 0.47 | 0.68 | 0.61 |
|
|
| |||||||||||||||||||
|
| .86 | 0.91 | 0.71 | |||||||||||||||||||||||||||||||||
|
| FC1 | 0.34 | 0.59 | 0.22 | 0.38 |
| 0.40 | 0.49 | 0.40 | 0.41 | 0.39 | 0.29 | 0.38 | 0.37 |
|
|
| |||||||||||||||||||
|
| FC2 | 0.40 | 0.70 | 0.25 | 0.44 |
| 0.45 | 0.50 | 0.38 | 0.39 | 0.37 | 0.27 | 0.43 | 0.36 |
|
|
| |||||||||||||||||||
|
| FC3 | 0.44 | 0.64 | 0.25 | 0.45 |
| 0.52 | 0.57 | 0.43 | 0.44 | 0.42 | 0.32 | 0.43 | 0.36 |
|
|
| |||||||||||||||||||
|
| FC4 | 0.29 | 0.39 | 0.26 | 0.31 |
| 0.41 | 0.52 | 0.40 | 0.43 | 0.33 | 0.33 | 0.33 | 0.30 |
|
|
| |||||||||||||||||||
|
| .90 | 0.94 | 0.84 | |||||||||||||||||||||||||||||||||
|
| HM1 | 0.47 | 0.50 | 0.40 | 0.62 | 0.52 |
| 0.47 | 0.57 | 0.53 | 0.48 | 0.52 | 0.54 | 0.52 |
|
|
| |||||||||||||||||||
|
| HM2 | 0.52 | 0.53 | 0.43 | 0.70 | 0.54 |
| 0.53 | 0.60 | 0.59 | 0.50 | 0.53 | 0.61 | 0.55 |
|
|
| |||||||||||||||||||
|
| HM3 | 0.29 | 0.31 | 0.36 | 0.46 | 0.36 |
| 0.40 | 0.45 | 0.40 | 0.35 | 0.45 | 0.42 | 0.39 |
|
|
| |||||||||||||||||||
|
| .92 | 0.95 | 0.87 | |||||||||||||||||||||||||||||||||
|
| PV1 | 0.31 | 0.40 | 0.21 | 0.36 | 0.57 | 0.42 |
| 0.47 | 0.44 | 0.45 | 0.38 | 0.39 | 0.37 |
|
|
| |||||||||||||||||||
|
| PV2 | 0.35 | 0.43 | 0.28 | 0.46 | 0.58 | 0.47 |
| 0.50 | 0.49 | 0.47 | 0.40 | 0.50 | 0.47 |
|
|
| |||||||||||||||||||
|
| PV3 | 0.35 | 0.45 | 0.33 | 0.48 | 0.57 | 0.54 |
| 0.55 | 0.53 | 0.51 | 0.45 | 0.49 | 0.49 |
|
|
| |||||||||||||||||||
| .92 | 0.94 | 0.76 | ||||||||||||||||||||||||||||||||||
|
| PEM-PL1 | 0.52 | 0.39 | 0.56 | 0.59 | 0.45 | 0.51 | 0.52 | 0.82 |
| 0.67 | 0.63 | 0.57 | 0.61 |
|
|
| |||||||||||||||||||
|
| PEM-PL2 | 0.54 | 0.37 | 0.51 | 0.62 | 0.45 | 0.52 | 0.51 | 0.82 |
| 0.68 | 0.63 | 0.59 | 0.61 |
|
|
| |||||||||||||||||||
|
| PEM-PL3 | 0.54 | 0.33 | 0.51 | 0.54 | 0.40 | 0.50 | 0.44 | 0.85 |
| 0.68 | 0.67 | 0.56 | 0.60 |
|
|
| |||||||||||||||||||
|
| PEM-PL4 | 0.58 | 0.40 | 0.47 | 0.58 | 0.46 | 0.51 | 0.43 | 0.81 |
| 0.66 | 0.63 | 0.61 | 0.62 |
|
|
| |||||||||||||||||||
|
| PEM-PL5 | 0.46 | 0.27 | 0.39 | 0.46 | 0.38 | 0.42 | 0.38 | 0.67 |
| 0.58 | 0.52 | 0.47 | 0.47 |
|
|
| |||||||||||||||||||
|
| .90 | 0.93 | 0.77 | |||||||||||||||||||||||||||||||||
|
| PEM-CL1 | 0.56 | 0.39 | 0.45 | 0.54 | 0.43 | 0.45 | 0.43 | 0.80 | 0.73 |
| 0.61 | 0.57 | 0.59 |
|
|
| |||||||||||||||||||
|
| PEM-CL2 | 0.47 | 0.28 | 0.37 | 0.43 | 0.35 | 0.38 | 0.45 | 0.74 | 0.57 |
| 0.60 | 0.47 | 0.49 |
|
|
| |||||||||||||||||||
|
| PEM-CL3 | 0.50 | 0.34 | 0.45 | 0.49 | 0.40 | 0.46 | 0.49 | 0.81 | 0.66 |
| 0.67 | 0.54 | 0.58 |
|
|
| |||||||||||||||||||
|
| PEM-CL4 | 0.43 | 0.31 | 0.38 | 0.49 | 0.39 | 0.45 | 0.44 | 0.80 | 0.67 |
| 0.69 | 0.51 | 0.55 |
|
|
| |||||||||||||||||||
|
| .93 | 0.95 | 0.78 | |||||||||||||||||||||||||||||||||
|
| PEM-CCL1 | 0.37 | 0.24 | 0.43 | 0.47 | 0.29 | 0.48 | 0.36 | 0.78 | 0.60 | 0.63 |
| 0.49 | 0.51 |
|
|
| |||||||||||||||||||
|
| PEM-CCL2 | 0.37 | 0.24 | 0.38 | 0.43 | 0.27 | 0.45 | 0.38 | 0.78 | 0.60 | 0.63 |
| 0.45 | 0.49 |
|
|
| |||||||||||||||||||
|
| PEM-CCL3 | 0.38 | 0.31 | 0.45 | 0.51 | 0.38 | 0.53 | 0.41 | 0.81 | 0.64 | 0.63 |
| 0.56 | 0.55 |
|
|
| |||||||||||||||||||
|
| PEM-CCL4 | 0.46 | 0.30 | 0.48 | 0.53 | 0.34 | 0.52 | 0.43 | 0.85 | 0.71 | 0.67 |
| 0.60 | 0.59 |
|
|
| |||||||||||||||||||
|
| PEM-CCL5 | 0.31 | 0.19 | 0.43 | 0.41 | 0.28 | 0.44 | 0.35 | 0.75 | 0.57 | 0.64 |
| 0.45 | 0.47 |
|
|
| |||||||||||||||||||
|
| .95 | 0.97 | 0.90 | |||||||||||||||||||||||||||||||||
|
| BI1 | 0.65 | 0.38 | 0.44 | 0.66 | 0.42 | 0.51 | 0.46 | 0.63 | 0.62 | 0.56 | 0.53 |
| 0.76 |
|
|
| |||||||||||||||||||
|
| BI2 | 0.58 | 0.34 | 0.53 | 0.71 | 0.40 | 0.56 | 0.43 | 0.63 | 0.59 | 0.54 | 0.56 |
| 0.77 |
|
|
| |||||||||||||||||||
|
| BI3 | 0.66 | 0.44 | 0.50 | 0.71 | 0.50 | 0.59 | 0.52 | 0.66 | 0.63 | 0.60 | 0.56 |
| 0.78 |
|
|
| |||||||||||||||||||
| .93 | 0.95 | 0.82 | ||||||||||||||||||||||||||||||||||
|
| BIR1 | 0.59 | 0.33 | 0.53 | 0.65 | 0.36 | 0.53 | 0.48 | 0.67 | 0.63 | 0.61 | 0.58 | 0.77 |
|
|
|
| |||||||||||||||||||
|
| BIR2 | 0.53 | 0.36 | 0.32 | 0.50 | 0.37 | 0.40 | 0.44 | 0.54 | 0.54 | 0.50 | 0.41 | 0.64 |
|
|
|
| |||||||||||||||||||
|
| BIR3 | 0.58 | 0.33 | 0.51 | 0.65 | 0.38 | 0.52 | 0.42 | 0.65 | 0.62 | 0.59 | 0.57 | 0.77 |
|
|
|
| |||||||||||||||||||
|
| BIR4 | 0.57 | 0.32 | 0.51 | 0.61 | 0.38 | 0.51 | 0.40 | 0.66 | 0.63 | 0.58 | 0.58 | 0.73 |
|
|
|
| |||||||||||||||||||
aPE: performance expectation.
bEE: effort expectancy.
cSI: social influence.
dHT: habit.
eFC: facilitation conditions.
fHM: hedonic motivation.
gPV: price value.
hPEM: personal empowerment (second order).
iPEM-PL: personal empowerment-professional logic.
jPEM-CL: personal empowerment-consumer logic.
kPEM-CCL: personal empowerment-community logic.
lBI: behavior intention.
mBIR: behavior intention to recommend.
nCA: Cronbach alpha.
oCR: composite reliability.
pAVE: average variance extracted.
qNumbers in italics indicate loadings of the indicators for their own constructs.
Total sample descriptive statistics, correlations, and square root of average variance extracted.
| Variable | Mean (SD) | PEa | EEb | SIc | HTd | FCe | HMf | PVg | PEMh | PEM-PLi | PEM-CLj | PEM-CCLk | BIl | BIRm | Age | Education | Gender | PCHCn |
| PE | 4.90 (1.63) | 0.91o |
|
| ||||||||||||||
| EE | 4.90 (1.63) | 0.50 | 0.91o |
| ||||||||||||||
| SI | 5.41 (1.34) | 0.44 | 0.21 | 0.97o | ||||||||||||||
| HT | 5.18 (1.55) | 0.58 | 0.47 | 0.60 | 0.85o | |||||||||||||
| FC | 4.49 (1.58) | 0.44 | 0.70 | 0.28 | 0.47 | 0.84o | ||||||||||||
| HM | 3.84 (1.89) | 0.48 | 0.51 | 0.44 | 0.67 | 0.53 | 0.91o | |||||||||||
| PV | 5.23 (1.36) | 0.37 | 0.46 | 0.30 | 0.47 | 0.62 | 0.51 | 0.93o | ||||||||||
| PEM | 4.47 (1.54) | 0.59 | 0.40 | 0.56 | 0.64 | 0.48 | 0.60 | 0.54 | 0.79o | |||||||||
| PEM-PL | 4.21 (1.57) | 0.61 | 0.40 | 0.56 | 0.64 | 0.49 | 0.56 | 0.53 | 0.91 | 0.87o | ||||||||
| PEM-CL | 4.44 (1.54) | 0.56 | 0.38 | 0.47 | 0.56 | 0.45 | 0.49 | 0.51 | 0.90 | 0.75 | 0.88o | |||||||
| PEM-CCL | 4.75 (1.46) | 0.43 | 0.29 | 0.49 | 0.53 | 0.35 | 0.55 | 0.44 | 0.90 | 0.71 | 0.73 | 0.88o | ||||||
| BI | 4.34 (1.40) | 0.66 | 0.41 | 0.51 | 0.73 | 0.47 | 0.58 | 0.50 | 0.67 | 0.64 | 0.60 | 0.58 | 0.95o | |||||
| BIR | 4.04 (1.63) | 0.63 | 0.37 | 0.52 | 0.67 | 0.41 | 0.54 | 0.48 | 0.70 | 0.67 | 0.63 | 0.60 | 0.81 | 0.90o | ||||
| Age | 40.04 (13.6) | –0.08 | –0.29 | 0.24 | 0.05 | –0.10 | 0.03 | –0.11 | 0.04 | 0.09 | –0.05 | 0.04 | –0.01 | 0.00 | 1.00 | |||
| Education | N/Ap | 0.06 | 0.20 | –0.10 | –0.03 | 0.25 | 0.08 | 0.11 | 0.02 | 0.03 | 0.06 | –0.03 | 0.05 | 0.08 | –0.12 | 1.00 | ||
| Gender | N/A | 0.20 | 0.03 | 0.15 | 0.12 | 0.10 | 0.13 | 0.06 | 0.22 | 0.22 | 0.21 | 0.16 | 0.17 | 0.18 | 0.13 | –0.02 | 1.00 | |
| PCHC | N/A | –0.04 | –0.11 | 0.15 | 0.11 | –0.02 | 0.11 | –0.06 | 0.04 | 0.11 | –0.08 | 0.04 | 0.03 | 0.05 | 0.44 | –0.20 | –0.03 | 1.00 |
aPE: performance expectation.
bEE: effort expectancy.
cSI: social influence.
dHT: habit.
eFC: facilitation conditions.
fHM: hedonic motivation.
gPV: price value.
hPEM: personal empowerment (second order).
iPEM-PL: personal empowerment-professional logic.
jPEM-CL: personal empowerment-consumer logic.
kPEM-CCL: personal empowerment-community logic.
lBI: behavior intention.
mBIR: behavior intention to recommend.
nPCHC: presence of chronic health condition.
oSquare root of average variance extracted.
pN/A: not applicable.
Formative indicators for quality criteria.
| Indicator | VIFa | Loading | Weight | Loading | Weight |
| UBbf1: What is your actual frequency of use of mHealthc to collect biometric data for medical follow-up? | 2.10 | 0.74 | 0.21 | <.001 | .007 |
| UBf2: What is your actual frequency of use of mHealth to collect biometric data related to well-being (fitness apps)? | 1.68 | 0.84 | 0.45 | <.001 | <.001 |
| UBf3: What is your actual frequency of use of mHealth to access a patient portal (eg, manage appointments, results of clinical analysis, application for online prescription)? | 1.94 | 0.77 | 0.34 | <.001 | <.001 |
| UBf4: What is your actual frequency of use of mHealth to monitor therapeutic compliance/adhesion (prescribed drugs/medicine intake follow up)? | 2.01 | 0.53 | –0.06 | <.001 | .43 |
| UBf5: What is your actual frequency of use of mHealth for scientific observational studies (eg, medicine, app, or innovative treatment trial)? | 1.86 | 0.52 | 0.07 | <.001 | .45 |
| UBf6: What is your actual frequency of use of mHealth for health information research? | 1.80 | 0.64 | 0.11 | <.001 | .21 |
| UBf7: What is your actual frequency of use of mHealth for clinical screening and counselling? | 2.04 | 0.64 | 0.17 | <.001 | .04 |
| UBf8: What is your actual frequency of use of mHealth for making remote medical consultations/appointments? | 1.90 | 0.42 | 0.08 | <.001 | .34 |
| UBf9: What is your actual frequency of use of mHealth to request home medical consultation? | 1.64 | 0.31 | –0.14 | <.001 | .05 |
| UBf10: What is your actual frequency of use of mHealth to participate in peer support groups or online communities of patients? | 1.81 | 0.46 | 0.07 | <.001 | .48 |
aVIF: variance inflation factor.
bUB: use behavior.
cmHealth: mobile health.
Measurement model evaluation for the higher-order formative constructs personal empowerment.
| Constructs | VIFa | Weight | |
| Personal Empowerment - Community Logic | 2.44 | 0.38 | <.001 |
| Personal Empowerment - Consumer Logic | 2.76 | 0.32 | <.001 |
| Personal Empowerment - Professional Logic | 2.61 | 0.41 | <.001 |
aVIF: variance inflation factor.
Structural model results.
| Dependent/independent variables | β | ||||||||||||||||
|
| Total | CHPa | WCHCb | CHCP – WCHC | Total | CHCP | WCHC | CHCP – WCHC | Total | CHCP | WCHC | ||||||
|
| 66 | 74 | 65 | ||||||||||||||
|
| PEd | .29** | .46** | .22** | .19 | 5.13** | 5.20** | 3.13** | 1.68 |
|
|
| |||||
|
| EEe | –.11 | –.15 | –.05 | .15 | 1.76 | 1.43 | 0.71 | 1.07 |
|
|
| |||||
|
| SIf | .02 | –.10 | .11 | .04 | 0.38 | 1.79 | 1.36 | 0.43 |
|
|
| |||||
|
| HTg | .39** | .35** | .37** | .12 | 5.68** | 3.23** | 4.20** | 0.84 |
|
|
| |||||
|
| FCh | .04 | .16 | .00 | .07 | 0.56 | 1.42 | 0.06 | 0.46 |
|
|
| |||||
|
| HMi | .05 | –.10 | .10 | .16 | 0.87 | 1.01 | 1.51 | 1.25 |
|
|
| |||||
|
| PVj | .10 | .11 | .12 | .11 | 1.74 | 1.26 | 1.69 | 1.04 |
|
|
| |||||
|
| PEMk | .18* | .23* | .11 | .02 | 2.55* | 2.47* | 1.10 | 0.14 |
|
|
| |||||
|
| Age | –.04 | –.03 | –.03 | .00 | 1.06 | 0.54 | 0.70 | 0.00 |
|
|
| |||||
|
| Gender | .02 | .00 | .03 | .04 | 0.64 | 0.09 | 0.79 | 0.55 |
|
|
| |||||
|
| Education | .04 | .02 | .02 | .00 | 1.06 | 0.27 | 0.36 | 0.02 |
|
|
| |||||
|
| 54 | 51 | 63 | ||||||||||||||
|
| HT | .47** | .26 | .54** | .23 | 6.16** | 1.67 | 6.09** | 1.40 |
|
|
| |||||
|
| FC | .04 | –.01 | .09 | .14 | 0.68 | 0.13 | 1.44 | 1.17 |
|
|
| |||||
|
| PEM | .17** | .19 | .16* | .01 | 2.62** | 1.44 | 2.19 | 0.04 |
|
|
| |||||
|
| BI | .15 | .27 | .09 | .23 | 1.83 | 1.76 | 0.96 | 1.38 |
|
|
| |||||
|
| Age | –.04 | –.20* | .07 | .26 | 0.72 | 2.44* | 1.26 | 2.87** |
|
|
| |||||
|
| Gender | .02 | .06 | .00 | .07 | 0.47 | 0.81 | 0.06 | 0.74 |
|
|
| |||||
|
| Education | .10* | .10 | .05 | .05 | 2.33* | 1.12 | 0.92 | 0.56 |
|
|
| |||||
|
| 70 | 62 | 75 | ||||||||||||||
|
| PEM | .26** | .34** | .23** | .09 | 4.67** | 3.49** | 3.56** | 0.85 |
|
|
| |||||
|
| BI | .58** | .42** | .65** | .11 | 9.17** | 4.19** | 8.26** | 0.82 |
|
|
| |||||
|
| UB | .08 | .09 | .06 | .15 | 1.56 | 0.43 | 0.99 | 1.43 |
|
|
| |||||
|
| Age | –.01 | .00 | –.03 | .03 | 0.35 | 0.02 | 0.83 | 0.40 |
|
|
| |||||
|
| Gender | .01 | .01 | .00 | .01 | 0.37 | 0.17 | 0.06 | 0.10 |
|
|
| |||||
|
| Education | .04 | .10 | .03 | .07 | 1.38 | 1.73 | 0.78 | 1.08 |
|
|
| |||||
aCHCP: patients with chronic health conditions.
bWCHC: without chronic health conditions.
cBI: behavior intention.
dPE: performance expectation.
eEE: effort expectancy.
fSI: social influence.
gHT: habit.
hFC: facilitation conditions.
iHM: hedonic motivation.
jPV: price value.
kPEM: personal empowerment (second order).
lUB: use behavior.
mBIR: behavior intention to recommend.
** P<.01, *P<.05; df (bootstrap)=4999.
Figure 2Results of the structural model for the total sample. UTAUT: unified theory of acceptance and usage of technology; mHealth: mobile health.
Figure 3Structural model results for the chronic health conditions patients (CHCP) group and the without chronic health conditions (WCHC) group (in parentheses). Statistically significant relationships observed for both groups are presented in green. Significant relationships only in the WCHC group are presented in red. Results with no significant relationship in either group are presented in black with ns.
Summary of findings regarding the hypotheses.
| Hypothesis | Path | β | Result | |
| 1 (a) | PEa to BIb | .29 | 5.13** | Supported |
| 1 (b) | (PECHCPc to BICHCP) - (PEWCHCd to BIWCHC) | .19 | 1.68 | Not supported |
| 2(a) | EEe to BI | –.11 | 1.76 | Not supported |
| 2(b) | EE to PE to BI | .27 | 4.47** | Supported |
| 3 | HMf to BI | .05 | 0.87 | Not supported |
| 4 | SIg to BI | .02 | 0.38 | Not supported |
| 5 (a) | FCh to BI | .04 | 0.56 | Not supported |
| 5(b) | FC to UBi | .04 | 0.68 | Not supported |
| 5(c) | (FCCHCP to BICHCP) - (FCWCHC to BIWCHC) | .07 | 0.46 | Not supported |
| 5(d) | (FCCHCP to UBCHCP) - (FCWCHC to UBWCHC) | .14 | 1.17 | Not supported |
| 6 | PVj to BI | .10 | 1.74 | Not supported |
| 7(a) | HTk to BI | .39 | 5.68** | Supported |
| 7(b) | HT to UB | .47 | 6.16** | Supported |
| 8(a) | BI to UB | .15 | 1.83 | Not supported |
| 8(b) | BI to BIRl | .58 | 9.17** | Supported |
| 9 | UB to BIR | .08 | 1.56 | Not supported |
| 10(a) | PEMm to BI | .18 | 2.55* | Supported |
| 10(b) | PEM to UB | .17 | 2.62** | Supported |
| 10(c) | PEM to BIR | .26 | 4.67** | Supported |
| 10(d) | (PEMCHCP to BICHCP) - (PEMWCHC to BIWCHC) | .02 | 0.14 | Not supported |
| 10(e) | (PEMCHCP to UBCHCP) - (PEMWCHC to UBWCHC) | .01 | 0.04 | Not supported |
| 10(f) | (PEMCHCP to BIRCHCP) - (PEMWCHC to BIRWCHC) | .09 | 0.85 | Not supported |
aPE: performance expectation.
bBI: behavior intention.
cCHCP: patients with chronic conditions.
dWCHC: without chronic conditions.
eEE: effort expectancy.
fHM: hedonic motivation.
gSI: social influence.
hFC: facilitation conditions.
iUB: use behavior.
jPV: price value.
kHT: habit.
lBIR: behavior intention to recommend.
mPEM: personal empowerment.
** P<.01, *P<.05; df (bootstrap)=4999.
Median use behavior (UB) formative indicators in patients with chronic conditions according to age.
| UB formative indicators | Younger patients (<55 years; n=44), median | Older patients (≥55 years; n=80), median |
| UBf1: What is your actual frequency of use of mHealth to collect biometric data for medical follow-up? | 4.00 | 3.00 |
| UBf2: What is your actual frequency of use of mHealth to collect biometric data related to well-being (fitness apps)? | 4.00 | 3.00 |
| UBf3: What is your actual frequency of use of mHealth to access a patient portal (eg, manage appointments, results of clinical analysis, application for online prescription)? | 6.00 | 5.00 |
| UBf4: What is your actual frequency of use of mHealth to monitor therapeutic compliance/adhesion (prescribed drugs/medicine intake follow up)? | 4.00 | 3.00 |
| UBf5: What is your actual frequency of use of mHealth for scientific observational studies (eg, medicine, app, or innovative treatment trial)? | 2.00 | 3.00 |
| UBf6: What is your actual frequency of use of mHealth for health information research? | 5.00 | 5.00 |
| UBf7: What is your actual frequency of use of mHealth for clinical screening and counselling? | 3.50 | 3.50 |
| UBf8: What is your actual frequency of use of mHealth for making remote medical consultations/appointments? | 1.00 | 1.00 |
| UBf9: What is your actual frequency of use of mHealth to request home medical consultation? | 1.00 | 1.50 |
| UBf10: What is your actual frequency of use of mHealth to participate in peer support groups or online communities of patients? | 2.00 | 2.00 |